Prevalence and determinants of diabetic retinopathy and cataracts in West African type 2 diabetes patients

Ethnicity and Disease

Volumn 13, Issue 2 SUPPL. 2, 2003, Pages

  Rotimi, Charles ^a   Daniel, Harold ^a   Zhou, Jie ^a   Obisesan, Augustine ^a   Chen, Guanjie ^a   Chen, Yuanxiu ^a   Amoah, Albert ^b   Opoku, Victoria ^b   Acheampong, Joseph ^c   Agyenim Boateng, Kofi ^c   Eghan Jr , Benjamin Ackon ^c   Oli, Johnnie ^d   Okafor, Godfrey ^d   Ofoegbu, Ester ^d   Osotimehin, Babatunde ^e   Abbiyesuku, Fayeofori ^e   Johnson, Thomas ^f   Fasanmade, Olufemi ^f   Doumatey, Ayo ^a   Aje, Temilolu ^a   Collins, Francis ^g   Dunston, Georgia ^a   more..

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF GHANA   (Ghana)

^c KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^d UNIVERSITY OF NIGERIA   (Nigeria)

^e UNIVERSITY OF IBADAN   (Nigeria)

^f UNIVERSITY OF LAGOS   (Nigeria)

^g NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Cataracts; Retinopathy; Type 2 diabetes; West Africa

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CATARACT; CATARACTOGENESIS; COHORT ANALYSIS; CONTROLLED STUDY; DIABETIC RETINOPATHY; DIET RESTRICTION; DISEASE COURSE; DISEASE DURATION; FEMALE; GHANA; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROANEURYSM; NIGERIA; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; PREVALENCE; RETINA EDEMA; RETINA HEMORRHAGE; RETINA MACULOPATHY; RISK ASSESSMENT; RISK FACTOR; SPOUSE; VISUAL IMPAIRMENT; AFRICA; MIDDLE AGED;

ADULT; AFRICA, WESTERN; CATARACT; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 0042528353     PISSN: 1049510X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Palmberg PF. Diabetic retinopathy. Diabetes. 1977;26:703-709.
2. Retinopathy Working Party. A protocol for screening for diabetic retinopathy in Europe. Diabet Med. 1991;8:263-267.
3. Harris MI, Klein R, Welborn TA, Knuiman MW. Onset of NIDDM occurs at least 4-7 years before clinical diagnosis. Diabetes Care. 1992;15:815-819.
4. Jarrett Jr. Duration of non-insulin-dependent diabetes and development of retinopathy: analysis of possible risk factors. Diabet Med. 1986;3:261-263.
5. Aldington SJ, Kohner EM, Nugent Z. Retinopathy at entry in the United Kingdom Prospective Diabetes Study (UKPDS) of maturity onset diabetes. Diabet Med. 1987;4:355.
6. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years or more. Arch Ophthalmol. 1984;102:527-532.
7. Patrick AW, Leslie PJ, Clark BF, Frier BF. The natural history and associates of microalbuminuria in type 2 diabetes during the first year after diagnosis. Diabet Med. 1990;7:902-908.
8. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984;102:520-526.
9. Klein BEK, Moss SE, Klein R. Is menarche associated with diabetic retinopathy? Diabetes Care. 1990;13:1034-1038.
10. Murphy RP, Nanda M, Plotnick L, Enger C, Vitale S, Patz A. The relationship of puberty to diabetic retinopathy. Arch Ophthalmol. 1990;108:215-218.
11. Klein BEK, Moss SE, Klein R. Effect of pregnancy on progression of diabetic retinopathy. Diabetes Care. 1990;13:34-40.
12. Rodman HM, Singerman LJ, Aiello LM, Merkatz IR. Diabetic retinopathy and its relationship to pregnancy. In: Merkatz IR, Adams PAJ, eds. The Diabetic Pregnancy: A Perinatal Perspective. New York, NY: Grune and Stratton; 1979.
13. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. X. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1989;107:244-249.
14. Klein R, Klein BEK, Moss SE, Cruickshanks KJC. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol. 1994;112:1217-1228.
15. Mokdad AH, Ford ES, Bowman BA, et al. Diabetes trends in the US, 1990-1998. Diabetes Care. 2000;23:1278-1283.
16. Ballard DJ, Melton LJ, Dwyer MS, Trautmann JC, O'Fallon WM, Palumbo PJ. Risk factors for diabetic retinopathy: a population-based study in Rochester, Minnesota. Diabetes Care. 1986;9:334-342.
17. Nelson RG, Newman JM, Knowler WC, et al. Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians. Diabetologia. 1988;31:730-736.
18. Diabetes Drafting Group. Prevalence of small and large vessel disease in diabetic patients from 14 centers: The World Health Organization Multinational Study of Vascular Disease in Diabetes. Diabetologia. 1985;28:615-640.
19. LaPorte RE, Dorman JS, Tajima N, et al. Pittsburgh Insulin-Dependent Diabetes Mellitus Morbidity and Mortality Study: physical activity and diabetic complications. Pediatrics. 1986;78:1027-1033.
20. Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabet Med. 1997;14(suppl 5):S1-S85.
21. Henricsson M, Nystrom L, Blohme G, et al. The incidence of retinopathy 10 years after diagnosis in young adult people with diabetes. Diabetes Care. 2003;26:349-354.
22. Klein BEK, Moss SE, Klein R. Longitudinal measure of glycemic control and diabetic retinopathy. Diabetes Care. 1987;10:273-277.
23. Janghorbani M, Jones RB, Murray KJ, Allison SP. Incidence of and risk factors for diabetic retinopathy in diabetic clinic attenders. Ophthalmol Epidemiol. 2001;8(5):309-325.
24. Lewallen S, Courtright F. Blindness in Africa: present situation and future needs. Br J Ophthalmol. 2001;85:897-903.
25. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414-1431.
26. Ikem RT, Akinola NO, Balogun MO, Ohwovoriole AE, Akinsola A. What does the presence of hypertension portend in the Nigerian with non insulin dependent diabetes mellitus. West Afr J Med. 2001;20(2):127-130.
27. Neuhann HF, Water-Neuhann C, Lyaruu I, Msuya L. Diabetes care in Kilimanjaro region: clinical presentation and problems of patients of the diabetes clinic at the regional referral hospital - an inventory before structured intervention. Diabet Med. 2002;19(6): 509-513.
28. Drabo PY, Kabore J, Lengani A. Complications of diabetes mellitus at the Hospital Center of Ouagadougou. Bull Soc Pathol Exot. 1996;89:191-195.
29. Gebre-Yohannes A, Rahlenbeck SI. Glycemic control and its determinants in diabetic patients in Ethiopia. Diabetes Res Clin Pract. 1997;35:129-134.
30. Sidibe EH. Diabetic retinopathy in Dakar and African literature review: epidemiologic elements. Diabetes Metab. 2000;26(4):322-324.
31. Osuntokun BO, Akinkugbe FM, Francis TI, Reddy S, Osuntokun O, Taylor GO. Diabetes mellitus in Nigerians: a study of 832 patients. West Afr Med J Niger Pract. 1971;20: 295-312.
32. Sobngwi E, Mbanya JC, Moukouri EN, et al. Microalbuminuria and retinopathy in a diabetic population of Cameroon. Diabetes Res Clin Pract. 1999;44:191-196.
33. Levitt NS, Bradshaw D, Zwarenstein MF, et al. Audit of public sector primary diabetes care in Cape Town, South Africa: high prevalence of complications, uncontrolled hyperglycemia, and hypertension. Diabet Med. 1997;14:1073-1077.
34. Kalk WJ, Joannou J, Ntsep S, et al. Ethnic differences in the clinical laboratory associations with retinopathy in adult onset diabetes: studies in patients of African, European, and Indian origin. J Intern Med. 1997;24:31-37.
35. Elbagir MN, Eltom MA, Mahadi EO, et al. Pattern of long-term complications in Sudanese insulin-treated diabetic patients. Diabetes Res Clin Pract. 1995;30:59-67.
36. Kaimbo DK, Kabongo DK, Missotten L. Ocular complications in diabetes mellitus in Zaire. Bull Soc Belge Ophtalmol. 1995;255: 107-113.
37. Erasmus RT, Alanamu RA, Bojuwoye B, et al. Diabetic retinopathy in Nigerians: relation to duration of diabetes, type of treatment, and degree of control. East Afr Med J. 1989;66: 248-254.
38. Lester FT. Clinical features, complications, and mortality in type 2 (non-insulin dependent) diabetic patients in Addis Ababa, Ethiopia. Ethiop Med J. 1993;31:109-126.
39. Rotimi CN, Dunston GM, Berg K, et al. In search of susceptibility genes for type 2 diabetes in West Africa: the design and results of the first phase of the AADM Study. Ann Epidemiol. 2001;11:51-58.
40. American Diabetes Association. Screening for type 2 diabetes. Diabetes Care. 1992;22(suppl 1):S20-S23.
41. Seyoum B, Mengitsu Z, Berhanu P, et al. Retinopathy in patients of Tikur Anbessa Hospital diabetic clinic. Ethiop Med J. 2001;39: 123-131.
42. Nwosu SN. Low vision in Nigerians with diabetes mellitus. Doc Ophthalmol. 2000; 101(1):51-57.
43. Rotchford AP, Rotchford KM. Diabetes in rural South Africa - an assessment of care and complications. S Afr Med J 2002;92(7):536-541.
44. Porta M, Tomalino MG, Santoro F, et al. Diabetic retinopathy as a cause of blindness in the province of Turin, north-west Italy, in 1987-1991. Diabet Med. 1995;12:355-361.
45. Osuntokun BO. Diabetic retinopathy in Nigerians. A study of 758 patients. Br J Ophthalmol. 1969;53(10):652-663.
46. Levin L, Gelfand M. Diabetic retinopathy in African patients. S Afr Med J 1973;47:993-994.
47. Klein R, Klein BEK, Scott EM. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XVI. The relationship of C-peptide to the incidence and progression of diabetic retinopathy. Diabetes. 1995;44:796-801.
48. Aiello LP, Gardner TW, King GL, et al. Diabetic retinopathy. Diabet Care. 1998;21(1): 143-156.
49. Liebl A. Challenges in optimal metabolic control of diabetes. Diabetes Metab Res Rev. 2002; 18(suppl 3):S36-S41.
50. Klein R, Klein BEK, Moss SE, Cruickshanks KJ. The relationship of hyperglycemia to the long-term incidence and progression of diabetic retinopathy. Arch Intern Med. 1994;154: 2169-2178.
51. Teuscher A, Schnell H, Wilson PWF. Incidence of diabetic retinopathy and relationship to baseline plasma glucose and blood pressure. Diabetes Care. 1988;11:246-251.
52. Kostraba JN, Klein R, Dorman JS, et al. The epidemiology of diabetes complications study. IV. Correlates of diabetic background and proliferative retinopathy. Am J Epidemiol. 1991;133:381-391.
53. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long term complications in the diabetes control in insulin dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
54. United Kingdom Prospective Diabetes Study Group. UK prospective diabetes study VIII: study design, progress, and performance. Diabetologia. 1991;34(12):877-890.
55. United Kingdom Prospective Diabetes Study Group. UK prospective diabetes study 33: intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes. Lancet. 1998; 352(9131):837-853.
56. Hennekens C, Buring JE, Mayrent SL, eds. Epidemiology in Medicine. Philadelphia, Pa: Lippincott Williams & Wilkins; 1987.
57. King H, Rewers M. Global estimates for prevalence of diabetes mellitus and impaired glucose tolerance in adults. Diabetes Care. 1993;16:157-177.
58. Kohner EM. Diabetic retinopathy. Br Med J. 1993;307:1195-1199.
59. Klein R, Klein BEK, Moss SE. The epidemiology of ocular problems in diabetes mellitus. In: Fenman SS, ed. Ocular Problems in Diabetes Mellitus. Boston, Mass: Blackwell Scientific; 1992:1-52.
60. Backlund LB, Algvere PV, Rosenqvist U. New blindness in diabetes reduced by more than one-third in Stockholm County. Diabet Med. 1997;14:732-740.
61. Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin Epidemiology Study of Diabetic Retinopathy. VI. Retinal photocoagulation. Ophthalmology. 1987;94: 747-753.
62. Rolfe M. Diabetic eye disease in Central Africa. Diabetologia. 1988;31:88-92.